documents: FDA-2012-N-1037-0053

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2012-N-1037-0053 FDA FDA-2012-N-1037 Reference 22 - Abdel-Maksoud, M., B. House, M. Wasfy, et al., “In Vitro Antibiotic Susceptibility Testing of Brucella Isolates from Egypt between 1999 and 2007 and Evidence of Probable Rifampin Resistance,” - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act Supporting & Related Material Background Material 2014-06-05T04:00:00Z 2014 6     2014-06-06T03:05:38Z   0 0 090000648172c0e2

Links from other tables